Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Turcot syndrome × Celecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 16 Lung Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Breast Neoplasms 11 Head and Neck Neoplasms 8 Rectal Neoplasms 7 Prostatic Neoplasms 7 Mouth Neoplasms 5 Glioblastoma 5 Esophageal Neoplasms 5 Colonic Neoplasms 5 Central Nervous System Neoplasms 5 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Gliosarcoma 4 Ovarian Neoplasms 3 Oropharyngeal Neoplasms 3 Neuroblastoma 3 Hypopharyngeal Neoplasms 3 Carcinoma 3 Brain Neoplasms 3 Tongue Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Salivary Gland Neoplasms 2 Precancerous Conditions 2 Nasopharyngeal Neoplasms 2 Medulloblastoma 2 Locally Advanced Rectal Cancer 2 Laryngeal Neoplasms 2

Interventions

Nivolumab 5 pembrolizumab 3 Neoadjuvant Therapy 3 durvalumab 2 avelumab 2 atezolizumab 2 toripalimab 1 spartalizumab 1 relatlimab 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 danvatirsen 1 Surgical Procedures, Operative 1 Oxaliplatin 1 Leucovorin 1 Ipilimumab 1 Induction Chemotherapy 1 Immunotherapy 1 Immunoglobulin G 1 Immune Checkpoint Inhibitors 1 IMM-101 1 Fluorouracil 1 Docetaxel 1 Disulfides 1 DEAE-Dextran 1 Cyclophosphamide 1 Chemotherapy, Adjuvant 1 Celecoxib 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03926338 2025-11-20

PICC

Sun Yat-sen University

Phase 2 Recruiting

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡